Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MS

Fu I., 1998, J. Pharm. Biomed. Anal., 18, 357

Matuszewski B. K., 1998, Anal. Chem., 70, 889, 10.1021/ac971078+

Clarke S. D., 1996, Pharm. Sci., 2, 207

Constanzer M. L., 1997, J. Chromatogr., B, 693, 129

Matuszewski B. K., 1998, J. Chromatogr., B, 716, 208, 10.1016/S0378-4347(98)00317-X

Jemal M., 1999, Rapid Commun. Mass Spectrom., 13, 106

Buhrman D., 1996, J. Am. Soc. Mass Spectrom., 7, 1105, 10.1016/S1044-0305(96)00072-4

Kebarle P., 1993, Anal. Chem., 65, 986A, 10.1021/ac00070a716

Department of Health and Human Services, Food and Drug Administration, Guidance for Industry on Bioanalytical Method Validation., 2001, Fed. Regist., 66, 28526

Shah V. P., 2000, Pharm. Res., 17, 1557

Bonfiglio R., 1999, Rapid Commun. Mass Spectrom., 13, 1185, 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO;2-0

King R., 2000, J. Am. Soc. Mass Spectrom., 11, 950, 10.1016/S1044-0305(00)00163-X

Choi B. K., 2001, J. Chromatogr., A, 907, 342

Choi B. K., 2001, Fresenius' J. Anal. Chem., 369, 377

Chavez-Eng C. M., 2002, J. Chromatogr., B, 767, 129